Matthew L. Sherman, EVP & Chief Medical Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 2,615 shares at $15.62 ($41K) on 2024-02-16, disclosed to the SEC on 2024-02-20.
Seasonal sale ($41k) by EVP & Chief Medical Officer — this insider has traded DCPH in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $24K | — | Filing → |